NCT07903571
Cohort Study to eLucidAte Causes, Behaviour and Outcomes of gastRo Intestinal Tract Cancers in the Young
Not Yet Recruiting · Not specified · Royal Marsden NHS Foundation Trust · registry updated 2026-10-29
Inclusion and exclusion lines below are quoted from ClinicalTrials.gov. No match score is shown, because a score needs a person's age, biomarkers, and treatment dates. Confirm the record with the study team.
This study aims to better understand how gastrointestinal (digestive system) cancers develop and how they respond to treatment in young adults, in order to improve ways to prevent, diagnose, and manage these cancers in this age group.
Inclusion
- Cohort A: Colorectal Cancer including at least 20 patients with appendiceal cancer.
- Cohort B: Gastro-oesophageal cancer
- Cohort C: Hepato-biliary cancer
- Patient is 18-50 years of age 3 Patient can understand the patient information sheet and is able to provide written informed consent.
- \. Patient being treated at the Royal Marsden Hospital.
Exclusion
- Patients who have received prior treatment for their gastrointestinal malignancy (includes any systemic anti-cancer therapy, radiotherapy and / or surgical resection.
- Patients with a cancer of pancreatic origin (existing institutional biobank), or hepatocellular carcinoma (HCC)
- Patients with a history another of malignancy with within 2 years, excluding resected non melanomatous skin cancers.